Leidos (LDOS)
(Delayed Data from NYSE)
$166.39 USD
+1.24 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $166.39 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$166.39 USD
+1.24 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $166.39 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Zacks News
Intuitive Machines Stock Surges 180% Year to Date: Should You Buy Now?
by Aparajita Dutta
Investors interested in space stocks may buy LUNR, considering its year-to-date share price performance, solid backlog and strong liquidity.
LDOS vs. LMT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LDOS vs. LMT: Which Stock Is the Better Value Option?
Leidos Holdings (LDOS) Surges 48% YTD: Should You Buy Now or Later?
by Aparajita Dutta
This is the perfect time to buy LDOS, considering its discounted valuation, upbeat estimates and favorable macroeconomic environment supporting the growth of defense stocks.
Why Leidos (LDOS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here is What to Know Beyond Why Leidos Holdings, Inc. (LDOS) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Leidos (LDOS). This makes it worthwhile to examine what the stock has in store.
Zacks.com featured highlights include NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare
by Zacks Equity Research
NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare are part of the Zacks Screen of the Week article.
5 Dividend Growth Stocks Likely to Outperform Amid Low Rates
by Sweta Killa
NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.
Leidos Holdings, Inc. (LDOS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Leidos (LDOS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include Sterling Infrastructure, AXIS Capital, Leidos and Stride
by Zacks Equity Research
Sterling Infrastructure, AXIS Capital, Leidos and Stride are part of the Zacks Screen of the Week article.
Invest in These 4 Stocks With Amazing Interest Coverage Ratios Now
by Sumit Singh
STRL, AXS, LDOS & LRN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Why the Market Dipped But Leidos (LDOS) Gained Today
by Zacks Equity Research
Leidos (LDOS) concluded the recent trading session at $157.06, signifying a +0.62% move from its prior day's close.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Leidos (LDOS) Outperforming Other Aerospace Stocks This Year?
by Zacks Equity Research
Here is how Leidos (LDOS) and Textron (TXT) have performed compared to their sector so far this year.
Rocket Lab Stock Surges 30% YTD: Should You Buy Now or Later?
by Aparajita Dutta
Investors interested in RKLB should wait for a better entry point, considering its premium valuation. Those who already own this stock may continue to do so.
Lockheed Finishes Risk Reduction Test for TPY-4 Radar: Time to Buy?
by Aparajita Dutta
Investors interested in LMT should refrain from buying the stock right now, considering its premium valuation. However, its upbeat estimates and strong backlog remain major growth catalysts.
Reasons to Add Leidos Stock to Your Portfolio Right Now
by Zacks Equity Research
LDOS makes a strong case for investment in the Aerospace sector, given its solid earnings growth prospects, return on equity and rising backlog.
CACI to Acquire Azure Summit: Should You Buy, Sell or Hold the Stock?
by Zacks Equity Research
CACI International is set to acquire Azure Summit Technology to enhance its ISR, EW and SIGINT offerings.
LDOS or LMT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LDOS vs. LMT: Which Stock Is the Better Value Option?
Should BNY Mellon US Mid Cap Core Equity ETF (BKMC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for BKMC
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include Sterling, H&R Block, Leidos and Stride
by Zacks Equity Research
Sterling, H&R Block, Leidos and Stride have been highlighted in this Screen of The Week article.
Here's Why Leidos (LDOS) Fell More Than Broader Market
by Zacks Equity Research
In the latest trading session, Leidos (LDOS) closed at $152.85, marking a -1.89% move from the previous day.
Leidos (LDOS) Just Overtook the 200-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
4 Stocks That Stand Out on Attractive Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. STRL, HRB, LDOS & LRN are sound enough to meet financial obligations.
Zacks.com featured highlights include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare
by Zacks Equity Research
Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare are part of the Zacks Screen of the Week article.